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Abstract
Background: We describe the use of a conceptual framework and implementation protocol to
prepare effective health services interventions for implementation in community-based (i.e., non-
academic-affiliated) settings.
Methods: The framework is based on the experiences of the U.S. Centers for Disease Control
and Prevention (CDC) Replicating Effective Programs (REP) project, which has been at the
forefront of developing systematic and effective strategies to prepare HIV interventions for
dissemination. This article describes the REP framework, and how it can be applied to implement
clinical and health services interventions in community-based organizations.
Results: REP consists of four phases: pre-conditions (e.g., identifying need, target population, and
suitable intervention), pre-implementation (e.g., intervention packaging and community input),
implementation (e.g., package dissemination, training, technical assistance, and evaluation), and
maintenance and evolution (e.g., preparing the intervention for sustainability). Key components of
REP, including intervention packaging, training, technical assistance, and fidelity assessment are
crucial to the implementation of effective interventions in health care.
Conclusion: REP is a well-suited framework for implementing health care interventions, as it
specifies steps needed to maximize fidelity while allowing opportunities for flexibility (i.e., local
customizing) to maximize transferability. Strategies that foster the sustainability of REP as a tool to
implement effective health care interventions need to be developed and tested.
Background
Closing the gap between research and practice has been a
priority for many agencies, including the U.S. National
Institutes of Health, Veterans Health Administration
(VHA) and the Agency for Healthcare Research and Qual-
ity [1]. Despite the development of effective interventions
to improve health care quality, most of these interven-
tions have only been implemented in the academic set-
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tings in which they were developed, and few have been
successfully disseminated into non-academic-affiliated
(i.e., community-based) organizations [2]. A primary rea-
son for this research-to-practice gap is the lack of a frame-
work for implementing effective interventions in
community-based organizations that maintains fidelity
while maximizing transferability when the interventions
are adopted across different settings [2-4].
An effective strategy for implementing clinical and health
services (i.e., health care) interventions is needed. Many
interventions fail to achieve the outcomes observed when
tested in research settings once they are implemented in
community-based organizations. This "voltage drop" in
effectiveness maybe due to reduced fidelity to the inter-
vention when disseminated outside the academic realm to
community-based organizations, as well as lack of guid-
ance in customizing interventions to community-based
populations [5-8]. Moreover, stakeholders (e.g., health
care purchasers, plans, and providers) increasingly have to
choose which interventions to implement for their popu-
lations, and need guidance in implementing them in a
cost-efficient manner without diminishing the interven-
tion's effectiveness. At the same time, these stakeholders
need to ensure that the intervention will be accepted and
adopted across different organizations.
A number of strategies for guiding implementation efforts
have been proposed [9-14], many of which primarily
focus on adapting interventions by (a) determining when
an organization is "ready" to adapt or adopt an interven-
tion, and (b) working with senior leaders and frontline
providers to overcome barriers to adaptation. For exam-
ple, the VA's Quality Enhancement Research Initiative
(QUERI) framework outlines a process for choosing,
implementing, and marketing evidence-based interven-
tions in health care organizations [12]. Simpson describes
the underlying organizational characteristics that need to
be considered (readiness to change, resources, and cul-
ture) when planning an implementation of evidence-
based interventions [13]. Bartholomew et al. describe
Intervention Mapping, which involves planning an imple-
mentation of a program based on information from the
target population [14].
However, these frameworks do not address a fundamental
issue in implementation: achieving a balance between
adequate fidelity to the intervention and accommodating
differences across organizations in order to maximize the
effectiveness of the intervention. To date, no implementa-
tion frameworks have outlined strategies for maintaining
treatment fidelity while providing opportunities to adapt
interventions to fit local needs. For example, previous
frameworks do not provide specific guidance in replicat-
ing interventions for use in community-based organiza-
tions, and do not specify training or technical assistance
programs for facilitating implementation across different
settings. Without the appropriate tools and materials
available in a user-friendly format, community-based
organizations are less likely to implement an evidence-
based intervention; or if implemented, treatment fidelity
may be suboptimal.
In this article, we describe an innovative implementation
framework: Replicating Effective Programs (REP). In con-
trast to previously published implementation frame-
works, REP provides a roadmap for implementing
evidence-based interventions into community-based set-
tings through a combination of intervention "packaging,"
training, technical assistance, and other strategies to max-
imize the chances for sustaining the interventions. REP
has been empirically evaluated through a randomized
controlled trial of its effectiveness in achieving interven-
tion uptake and fidelity across different organizations
[15,16]. To date, other implementation frameworks have
included some but not all of the components of REP [9-
14], and there have been no evaluations of implementa-
tion frameworks that combine strategies to maximize
both fidelity and flexibility in implementing interven-
tions.
History and underlying theories of REP
REP was developed and applied by the U.S. Centers for
Disease Control and Prevention (CDC) to package and
disseminate HIV behavioral and treatment interventions
for implementation in community-based service settings,
notably AIDS service organizations [17]. CDC's REP
project was initiated in 1996 to address a critical link in
bridging research and practice; namely, packaging inter-
ventions so that they can be easily implemented in non-
academic, community-based settings. Extensive research
has focused on developing and evaluating interventions
designed to change risk behaviors related to HIV transmis-
sion since shortly after the first cases of AIDS were
reported in the United States [18]. The CDC's approach
involved: applying rigorous criteria to identify effective
interventions [19]; packaging interventions' complete sci-
entific protocols into non-technical language [20]; sup-
porting the implementation of the interventions through
training and technical assistance [21]; and providing
ongoing financial and technical support to sustain the
interventions' implementation [22-24].
The REP framework (Figure 1) builds on a systematic lit-
erature review and community input [19-24]. The con-
cepts underlying the REP packaging process derive from
action anthropology (wherein a neutral party mediates
interaction and exchange between two cultures – in this
case, research and practice) [25] and principles of health
promotion [26]. The foundational theories for dissemi-Implementation Science 2007, 2:42 http://www.implementationscience.com/content/2/1/42
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nating the interventions are Diffusion of Innovation,
which posits that innovations pass through particular
communication channels among members of a social sys-
tem over time [24], and Social Learning Theory, which
describes the relationship between behavior change and
persons' beliefs about their ability to change and the
results of the change [27].
REP components
There are four phases to REP [22]: pre-conditions, pre-
implementation, implementation, and maintenance and
evolution (Figure 1). The four phases are described in
detail in Table 1 as they would apply to health care inter-
ventions. When disseminating interventions, the first
three phases of REP (pre-conditions, pre-implementation,
and implementation) are most appropriate for the "early
adopter" and "early majority" types of community-based
settings based on the Rogers Diffusion of Innovation
model [24]. The final phase, maintenance and evolution,
is more appropriate for organizations described as the
"late majority" or "laggards" based on the Rogers model,
as they are more likely to participate once the intervention
is already being used by other organizations and with
appropriate organizational and financial incentives [24].
Pre-conditions
Pre-conditions for intervention adoption are: the identifi-
cation of the need for a new intervention for a target pop-
ulation; identification of an effective intervention that fits
local settings (e.g., mission of organization and benefits to
the organization) and the intended target population
(e.g., behavioral risks and culture); identifying implemen-
tation barriers; and drafting a user-friendly manual (i.e.,
"package") of the intervention.
Identifying need
The first step of the pre-conditions phase is to identify
appropriate at-risk populations and suitable evidence-
based interventions.
Identifying effective interventions
Interventions are suitable for REP if they have been rigor-
ously evaluated (e.g., via randomized controlled trials or
other quantitative studies) and have produced statistically
significant positive effects on the health outcomes of
interest.
Ensuring intervention fits local settings
In reviewing effective interventions, researchers should be
cognizant of whether the intervention has been shown to
be effective in patient populations similar to those in the
organizations taking part in the implementation process.
Many community-based organizations serve a dispropor-
tionate number of low income, minority, and co-mor-
bidly ill patients when compared to patients from
academic settings. Another consideration is determining
what the "usual care" conditions were in the effectiveness
studies. Often academic practices have resources that facil-
itate the conduct of research studies (e.g., staffing, elec-
tronic medical records, space), which many community-
based organizations lack.
Identifying implementation barriers
To ensure that the intervention is feasible in local settings,
researchers should meet with the staff members from par-
ticipating organizations, introduce the intervention, and
conduct an assessment of potential barriers to its imple-
mentation. Such meetings also foster buy-in, especially if
the researchers develop a list of benefits of participation,
from training opportunities to potential cost savings (i.e.,
the "business case"). During these meetings, researchers
should gather information in the form of a needs assess-
ment to benchmark usual care, including resources and
functioning characteristics that may directly affect the
mode by which the intervention will be implemented and
the types of technical assistance that might be needed
(e.g., staffing, patient volume, management characteris-
tics, information technology capability). This information
can inform the content of the intervention package.
Replicating effective programs framework for health care interventions Figure 1
Replicating effective programs framework for health care interventions. This figure outlines the Replicating Effective 
Programs (REP) process as it can be applied to health care interventions.
ing
Pre-Conditions
Identification of need
for new intervention
Identification of 
effective intervention
that fits local settings
Packaging intervention
for training and
assessment
Pre-Implementation
Orientation
 Explain core
elements
 Customize delivery
Logistics planning
Staff training
Technical assistance
Implementation
Ongoing support of and
partnership with
community organizations
Booster training
Process evaluation
Feedback and refinement
of intervention package
and train
Maintenance and
Evolution
Organizational and
financial changes to
sustain intervention
Prepare package for
national dissemination
Re-customize delivery as
need arises Implementation Science 2007, 2:42 http://www.implementationscience.com/content/2/1/42
Page 4 of 10
(page number not for citation purposes)
Drafting the intervention package
An intervention package is then drafted that is suitable for
implementation in community-based organizations.
Training and technical assistance plans are also drafted
during this phase. Packaging involves the conversion of
intervention protocols into non-academic language and
into a user-friendly manual that can be readily dissemi-
nated [20]. The package should be drafted by the develop-
ers of the intervention, but edited by non-technical writers
to ensure that the intervention package materials are free
of technical jargon. Supporting documents, such as a staff
training curriculum, a technical assistance guide, and pro-
motional materials are also included. The package is
refined and finalized during the pre-implementation
phase of REP based on input from the pilot-testing organ-
izations.
The REP intervention package conveys the intervention's
theoretical foundation (i.e., core elements), components,
and methods. Core elements – the critical features of the
design and intent of the intervention that are thought to
be responsible for the intervention's effectiveness – are
Table 1: Outline of REP process for health services-based interventions
Phase Activity Process Who
Pre-conditions Identify need --Identify high-burden condition Researchers
--Identify barriers to implementation
Identify effective intervention --Identify intervention tested in a 
completed, randomized controlled 
study
Researchers
Identify barriers --Organizational needs assessment, 
usual care
Researchers, representatives from 
practices, providers of community-
based organizations (target 
population)
Draft package --Write package into everyday 
language
Intervention developers
--Distinguish core elements, menu 
options
Pre-implementation Community Working Group --Select Community Working Group 
(CWG)
Researchers, CWG (i.e., health plans, 
practices, providers, patients, 
purchasers)
--Refine package, Core elements and 
menu options refined based on CWG 
input, adjudicated by intervention 
developers
--Refine training, technical assistance 
approach strategies per CWG input
Pilot test package --Further refinement of package Researchers, CWG
Orientation --Identify eligible organizations Researchers, CWG, organizations 
participating in implementation
--Logistics of dissemination
--Kick-off meeting, package 
dissemination
Implementation Training --Organization staff training Researchers and staff
Technical assistance --Follow-up with organizations Technical assistance expert
Evaluation --Formative evaluation Researchers
--Model fidelity
--Patient outcomes
--Return on investment
Ongoing support --Continue CWG, site visits Researchers, CWG
Feedback and refinement --Analyze data, inform sustainability CWG, Researchers
--Refine package
Maintenance and evolution Organizational, financial changes --CWG advises on sustainability 
strategies
Researchers, CWG, sites
--Develop business case for 
intervention and REP process
National dissemination --Reproduce package Researchers, CWG
--Refine business case: return on 
investment
Re-customize delivery as need 
arises
--Continue to refine package (e.g., 
menu options)
Researchers, CWGImplementation Science 2007, 2:42 http://www.implementationscience.com/content/2/1/42
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essential for maintaining fidelity. Still, while core ele-
ments are standardized, the mechanisms by which they
can be operationalized may vary across organizations. The
package can therefore articulate menu options for adapt-
ing intervention delivery across different organizations to
allow flexibility in implementation. For example, menu
options for organizations with a substantial number of
minorities may include culturally appropriate options for
delivering the intervention, such as outreach to families or
community groups. Prior evidence from the management
literature suggests that articulating a priori the core ele-
ments and adaptation options of a new product to poten-
tial users of the product is necessary for its successful
adaptation [28]. Thus, having the core elements detailed,
while also providing options for implementing these core
elements, is vital for optimizing both fidelity to the inter-
vention and flexibility in its implementation.
The REP packaging process has distinct advantages over
current strategies for disseminating interventions. For
example, a number of behavioral health intervention
toolkits (i.e., descriptions of the intervention compo-
nents) have been published or posted on websites, such as
the U.S. Substance Abuse and Mental Health Services
Administration's National Health Information Center
Evidence-Based Practices website [29]. However, unlike
REP packages, these toolkits often lack a detailed descrip-
tion of the intervention's set-up procedures, underlying
theories and logic flow, scripts, and other specific materi-
als, as well as instructions for implementing these materi-
als across different settings. In contrast, REP packages
provide specific details regarding the intervention as well
as operationalized options for adapting delivery of inter-
vention core elements to local organizations in a way that
does not compromise the intervention's core elements.
The REP packaging process has already been widely used
by the CDC to successfully implement and disseminate
HIV interventions. For example, between 1996 and 2005,
the REP project packaged ten interventions for use by
health departments, clinics, and community-based organ-
izations; and more packages are now being prepared.
CDC and state health departments fund the implementa-
tion of REP-packaged interventions by over 500 preven-
tion organizations nationwide [30].
Pre-implementation
Pre-implementation involves 1) input from a Community
Working Group (CWG) on developing the package, train-
ing, and technical assistance programs, 2) package pilot
test, and 3) orientation and logistics in preparing the
intervention for implementation.
Community working group – develop package
To accomplish the aims of the pre-implementation phase,
the intervention developer convenes a group of stakehold-
ers from organizations serving the target population to
participate in a Community Working Group (CWG). We
use a comprehensive definition of stakeholders based on
the Pincus multi-level 6-P framework that describes the
different levels of health care: populations (i.e., commu-
nities), purchasers, plans, practices, providers, and
patients (consumers) [30]. Given that these different lev-
els play an important role in the use of REP to implement
interventions, representatives from all levels should be
considered for active participation in the CWG. For exam-
ple, providers would be knowledgeable of the day-to-day
barriers to implementing the intervention, consumers can
comment on participant recruitment and burden, and
health plan leaders can provide input on how to sustain
the intervention beyond the REP implementation phase
(e.g., reimbursement of intervention services). CWG par-
ticipants should be persons who have influence over their
peers (i.e., opinion leaders), yet at the same time provide
input on the real-world experiences and have the clout to
leverage any necessary changes to minimize barriers to
intervention implementation.
The CWG members meet regularly throughout the pre-
implementation phase to review the intervention materi-
als, finalize the prototype package, advise on the staff
training and technical assistance plans, and plan the logis-
tics of the implementation. The goal of these meetings is
to review and advise on the package content and develop
options suitable for customizing the intervention to spe-
cific institutions (e.g., different options for organizing
group sessions, care manager communication protocols
with providers, guideline dissemination techniques). The
intervention developers or researchers familiar with the
science and core elements of the intervention should also
participate in the CWG in order to provide expertise in the
intervention. Notably, core elements and menu options
are refined based on CWG input, but the final decisions to
include menu options are made by the intervention devel-
opers/researchers. Whenever possible, notes should be
taken at the CWG meetings to preserve insight and feed-
back on the package and implementation process gar-
nered from the CWG members.
The final package should include the following compo-
nents: the intervention technical manual, training curric-
ulum, and guidance for the technical assistance. The
technical manual contains a general overview (operation-
alized core elements, recruitment tips, and selling points
for organization staff and leaders on the return on invest-
ment); intervention materials (verbatim scripts, and rec-
ommendations such as selecting an appropriate venue to
conduct the intervention), as well as session workbooks
and exhibits; a document describing staff members' roles,
time and resource requirements, job qualifications for
staff involved, and supervision guidelines; electronic filesImplementation Science 2007, 2:42 http://www.implementationscience.com/content/2/1/42
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of printable materials pertinent to the intervention; and
pocket cards, flowsheets, and other materials to facilitate
the intervention implementation. All materials should be
able to be photocopied and easy to read.
Pilot testing the package
Once the package has been reviewed by the CWG, it can
be tested for clarity and functionality within a few inter-
vention sites. During this process, the organizations can
identify five to eight patients to participate in a full inter-
vention cycle, and study investigators should collect infor-
mation on feasibility, acceptance, and any problems with
the overall package, so that the package can be refined
based on their input.
Orientation and logistics
Based on input from the site visits, needs assessments,
pilot test, and CWG, the prototype intervention package,
training, and technical assistance plans should be final-
ized for distribution. The package can be distributed
through orientation meetings, which can be helpful in
bringing recipient organizations together as well. Prior to
package distribution, a program champion should be
identified at each organization. Program champions can
help identify appropriate staff members who can imple-
ment the intervention and mobilize support for the inter-
vention within their organization. Program champions,
along with key staff members who will be implementing
the intervention, should be asked to attend the orienta-
tion meeting.
Implementation
The implementation phase begins upon the dissemina-
tion of the REP package to organizations, and continues
with intervention training, technical assistance, and eval-
uation (e.g., fidelity and outcomes monitoring). The CWG
continues to be involved in this phase to assist researchers
in interpreting feedback from the evaluation process.
Training
Training of selected staff members at participating organ-
izations is essential in implementing and sustaining the
intervention. The training should begin soon after pack-
age dissemination and should review the manuals and
include role playing to showcase specific communication
skills with participants. Booster training sessions should
also be implemented later in the implementation process.
Technical assistance
The technical assistance (TA) component usually occurs
after training and involves regular phone calls with the
organization representative within a month after training
is complete. Regular calls are necessary in order for the TA
experts to be proactive rather than reactive when prob-
lems regarding implementation need to be solved. The
trained TA specialist takes notes during the call and docu-
ments implementation progress at each organization. He
or she also advises on how to maintain fidelity (e.g., dis-
cerning core elements from menu options), integration
with existing services, and troubleshooting the implemen-
tation process. One of the biggest challenges is ensuring
that the core elements are maintained (fidelity) while its
implementation is customized and adapted to local
design specifications (flexibility). The TA specialist should
be encouraged to discuss the tension between fidelity and
adaptability with organizations, stressing that the essen-
tial core elements can be implemented using different
methods while remaining consistent with the interven-
tion's intent, and to provide positive feedback on the
organization's efforts. The TA specialist should also be
trained to address fidelity issues with both more- and less-
experienced employees, as the former may be reluctant to
change their traditional ways of patient care, while the lat-
ter may require more intensive training.
Evaluation
Four types of evaluation strategies ought to be considered:
interpretative evaluation of the intervention implementa-
tion process; measurement of intervention fidelity at the
organization and patient level; patient-level outcomes;
and return on investment (e.g., costs). Interpretative eval-
uation involves collection of data via qualitative inter-
views of providers and consumers to determine how the
intervention was actually implemented, and notes from
training and TA calls to determine to what extent these
programs were useful for the organizations. Intervention
fidelity measures should be developed to determine
whether core elements were successfully implemented.
For example, medical charts and staff logs can be used to
count the frequency and intensity of services provided, as
well as patient attendance and adherence, and staff inter-
views can be used to gather additional information on
whether core elements were implemented correctly.
Patient-level outcomes, including processes of care and
clinical and functional outcomes, should be chosen based
on which outcomes the intervention was designed to
impact. The return on investment (e.g., cost-benefit, or
how does the cost of implementing the intervention com-
pare to the savings in patient care) is one of the most
important evaluations to be conducted, and represents a
key argument in making the business case for the inter-
vention to stakeholders (e.g., health care purchasers,
plans, and consumers).
Feedback and refinement
Once the evaluation is complete, results should be vetted
to the CWG for input and suggestions on how to refine
the package for further dissemination. In addition, stake-
holders on the CWG with knowledge and leverage overImplementation Science 2007, 2:42 http://www.implementationscience.com/content/2/1/42
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the financing of care should consider how the interven-
tion could be sustained beyond the implementation.
Maintenance and evolution
Maintenance and evolution involve organizational or
financial changes to sustain the intervention (e.g., incor-
poration into job duties, securing funding, and training
new personnel), re-customizing intervention delivery as
circumstances change, and preparing the refined package,
training, and TA program for national dissemination. This
phase is often considered the most challenging and least
studied, in part because its key component (sustaining
interventions) involves concerted multilevel efforts to
change the current practice and the organizational and
financial incentives to make possible long-term national
adoption. For example, one of the most promising strate-
gies to sustain health services interventions is to create
billable services based on the intervention's core ele-
ments. Among health care purchasers and health plans,
sustainability may involve making the business case for
initiating financial incentives to provide services that are
crucial to the intervention. Sustaining these changes may
require strategies beyond financial incentives, such as
publicizing results on improved outcomes. Ultimately,
good evaluation data, especially on quality performance
measures and the return on investment, are essential for
making the business case for these changes.
Applying the REP process to health care settings
REP is a promising approach to implement effective clin-
ical and health services interventions in community-
based settings because many of these interventions
involve complex behavioral components akin to HIV pre-
vention interventions (e.g., group psychoeducation and
individual self-efficacy training). There are several lessons
learned from CDC's experience of REP that can be applied
to implementing interventions in routine health care set-
tings: time and resources are needed to develop prototype
packages of effective interventions so that they have fidel-
ity to the original intervention trial procedures and yet are
presented in language that is friendly to community-
based organizations; staff orientation and training are
essential for the faithful replication of effective interven-
tions; and when materials and training are given in ways
that are accessible to community-based organizations, sci-
ence-based intervention procedures are enthusiastically
adopted.
Moreover, the barriers and facilitators to implementation
addressed by REP experienced by AIDS service organiza-
tions are similar to those experienced in other health care
settings. Table 2 presents a summary of the barriers faced
by health care organizations in implementing evidence-
based interventions, along with examples of how REP
addresses these barriers. The Table is based on the Pincus
6-P model of barriers to implementing interventions [30].
Health care purchasers, notably Medicaid and employers,
are often unaware of the array of evidence-based interven-
tions available; nor have they been given the business case
for investing in the REP implementation framework.
Health plans face barriers to implementing evidence-
based interventions because of the lack of financial incen-
tives for doing so and/or because of bureaucratic complex-
ity associated with different contractual arrangements
across different provider organizations. As with many
AIDS service organizations that have participated in REP,
many health care settings face limited funding and
bureaucratic norms that preclude many interventions
Table 2: How REP addresses multilevel barriers to implementing effective treatments in health care settings
Level Barriers REP components addressing barriers
Health care purchasers Lack of awareness of evidence-based interventions
Lack of a "business case" for technology transfer models
Business case for REP process (added value of training/TA) 
via evaluation
Health plan Different provider organizations fragment implementation 
efforts
Lack of financial incentives to implement intervention
Package can be disseminated to several sites
REP training
Community Working Group (CWG) to include plan/
purchaser and minority representatives- match model to 
program/state mandates
Practice organizations Lack of time, resources to train staff in intervention
Interventions not adapted to practice organization
Lack of engagement if intervention is imposed on them
Manual and guidance on intervention application through 
TA to facilitate customization to local sites based on input 
from site representatives from CWG, enhance group 
scheduling, phone self-management sessions, and culturally 
appropriate options including community and family 
engagement
Provider Lack of time, information
Lack of training opportunities in intervention
Competing priorities
REP packaging- manual on how to supplement provider 
services
Patient/consumer Lack of access to customized interventions
Lack of ongoing support, interest
Identification and packaging of interventions tailored to 
different populations; Identification of intervention core 
elementsImplementation Science 2007, 2:42 http://www.implementationscience.com/content/2/1/42
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from being adopted without an a priori implementation
strategy [6].
In addition, many front-line providers lack the time and
tools to implement interventions in everyday practice,
and often feel that these interventions are being imposed
on them without their input [7]. Finally, at the patient
level, the HIV intervention literature has taught us that
one size does not fit all, and that intervention and dissem-
ination efforts need to be customized to particular patient
populations [18,19]. This means that separate interven-
tion packages ought to be considered for different groups
if there is substantial evidence that the intervention has a
differential effect on outcomes across group differences
(i.e., moderator effects).
Discussion: future directions
Closing the gap between research and practice is a priority,
especially for community-based practices outside the aca-
demic realm. The implementation of effective interven-
tions in community-based organizations has been
impeded by the multilevel barriers across the health care
system. Practical frameworks to facilitate the implementa-
tion of interventions in routine care settings are needed to
facilitate a more rapid implementation of research into
practice. REP is a promising tool that can be generalized
to implement and disseminate clinical and health services
interventions [15].
Nonetheless, REP has not been evaluated for its effective-
ness beyond disseminating HIV prevention interventions,
nor has it been evaluated for its effect on patient outcome
or costs (return on investment). Kelly and colleagues [16]
conducted the first randomized controlled trial of REP in
over 70 AIDS service organizations from across the U.S.
Organizations were randomized to receive the REP pack-
age, or the package, training, and TA. Those receiving the
package, training, and TA were more likely to use the
intervention, and intervention fidelity was greater than
the package-only group. Moreover, REP was equally effec-
tive in implementing different types of HIV interventions
(e.g., group-level and individual-level) for different popu-
lations (e.g., at-risk women, injection drug users, etc.)
However, it was not known whether TA and training
improve outcomes at the patient level above and beyond
packaging alone, and whether the added time and costs of
training/TA result in a more successful implementation of
the intervention and improved patient outcomes.
Furthermore, a more thorough assessment of what consti-
tutes an intervention core element is needed. Many health
services interventions are limited in their ability to be rep-
licated because they often involve multiple components
that are idiosyncratic to the particular setting. Hence, a
more sophisticated analysis of intervention mediators, or
active ingredients, is warranted in order to develop a more
precise logic flow between the intervention core element
and desired outcome.
Moreover, there have been no comprehensive studies of
the long-term effects of REP beyond the implementation
phase (i.e., sustainability). For example, implementation
fidelity may change in the months and years following
training, and as the intervention package is disseminated
to organizations that are at different stages of adoption
(e.g., late majority, laggards, per Rogers' diffusion model).
There is also little research on the degree to which this
final phase could or should be tailored for different types
of adopters. For example, are the late majorities and lag-
gards more likely to respond to financial incentives, or
should a technical assistance program be adapted specifi-
cally for them? Further research is needed on whether the
added investment of training and technical assistance can
mitigate this voltage drop in fidelity and patient-level
effect, especially across the different stages of adoption.
Moreover, incentives used in health services to promote
long-term sustainability of an intervention, such as billing
codes, performance measures, or administrative changes
(e.g., job function changes) show promise but have not
been fully studied on a large scale.
Applying the REP framework to health services interven-
tions can potentially address these knowledge gaps, nota-
bly through studies focused on whether interventions
packaged through the REP process improve patient out-
comes, and which of the intervention's key components
are likely to foster its sustainability beyond the implemen-
tation phase. For example, we are evaluating the effective-
ness of REP in implementing a bipolar disorder care
program within community-based practices using a rand-
omized controlled trial approach (e.g., randomizing
organizations to receive training and technical assistance
versus dissemination of the bipolar disorder program
package alone). Nonetheless, quasi-experimental designs
with non-equivalent comparison groups are promising
alternatives, especially if health care organizations are
resistant to randomization, or if there are insufficient
numbers of sites. Such designs can also be conducted on
a larger scale, especially if patient outcomes are measura-
ble at the population level (i.e., using claims data), avoid-
ing the expense of primary data collection.
Conclusion
Overall, REP is an valuable framework for implementing
health care interventions, as it specifies steps needed to
maximize fidelity to effective interventions while allowing
opportunities for flexibility (i.e., community input) to
maximize transferability. REP should be further applied to
implement health services interventions and evaluated for
its effectiveness in implementing different interventionsImplementation Science 2007, 2:42 http://www.implementationscience.com/content/2/1/42
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in health care settings. Strategies that foster the long-term
outcomes and sustainability of REP as a tool to imple-
ment effective health care interventions need to be devel-
oped and tested in health care settings.
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